Nowadays, biological therapies such as Anti-TNF-alpha biologic compounds (e.g. Infliximab) alone or in combination with immunosuppressives have shown great efficacy in IBD and have been considered as the gold standard in IBD therapeutic strategy [8]. This evidence concerns the gene TNF and inflammatory bowel disease.